Mark L. Gonzalgo, M.D., Ph.D.
Publications
- Stage I testicular seminoma: a SEER analysis of contemporary adjuvant radiotherapy trends. J Urol. 2013
- Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder. Urol Oncol. 2012 Jul-Aug; (4): 428-33
- Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center. Hum Pathol. 2012; (2): 254-60
- Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes. BJU Int. 2012; (6): 898-905
- Learning from our patients: complications and the future of radical cystectomy for bladder cancer. J Urol. 2012; (6): 2018
- Editorial comment. J Urol. 2011; (1): 35-6
- Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching. BJU Int. 2011; (12): 1956-62
- Minimally invasive training in urologic oncology. Arch Esp Urol. 2011; (9): 865-8
- Significance of preoperative PSA velocity in men with low serum PSA and normal DRE. World J Urol. 2011; (1): 11-4
- Use of magnetic resonance imaging to accurately detect and stage prostate cancer: the hype and the hope. J Urol. 2011; (5): 1756-7
- Prognostic features and markers for testicular cancer management. Indian J Urol. 2010 Jan-Mar; (1): 76-81
- Editorial comment. J Urol. 2010; (5): 1750
- Editorial comment. J Urol. 2010; (2): 459; discussion 459
- Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy. Cancer. 2010; (23): 5517-26
- Laparoscopic retroperitoneal lymph node dissection with therapeutic intent in men with clinical stage I nonseminomatous germ cell tumors. J Endourol. 2010; (11): 1759-63
- Renal pseudoaneurysm: an overview. Nat Rev Urol. 2010; (11): 619-25
- Robotic surgical training of the urologic oncologist. Urol Oncol. 2009 Mar-Apr; (2): 214-7
- Training the urologic oncologist of the future: where are the challenges? Urol Oncol. 2009 Mar-Apr; (2): 192
- Editorial comment. J Urol. 2009; (3): 913
- Editorial comment. J Urol. 2009; (5): 2248; discussion 2248-9
- Editorial comment. J Urol. 2009; (5): 2380-1
- Editorial comment. J Urol. 2009; (4): 1311-2
- Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer. Urology. 2009; (6): 1276-80
- Regarding: 'High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series'. Br J Cancer. 2009; (12): 2057-8; author reply 2059
- Reply. Urology. 2009; (6): 1281
- Surgery: laparoscopic prostatectomy: learning curve and cancer control. Nat Rev Urol. 2009; (7): 361-2
- Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system. J Urol. 2009; (4): 1364-70
- Urethral carcinosarcoma from bladder carcinosarcomatous lesions: analysis of clinicopathological features. Can J Urol. 2009; (1): 4512-5
- Words of wisdom. Re: Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. Hellenthal NJ, Ramirez ML, Evans CP, deVere White RW, Koppie TM. Eur Urol. 2009; (3): 571-2
- Application of Evicel to cavernous nerves of the rat does not influence erectile function in vivo. Urology. 2008; (5): 1169-73
- Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching. Urology. 2008; (6): 1246-51
- Minimally invasive surgical approaches and management of prostate cancer. Urol Clin North Am. 2008; (3): 489-504, ix
- Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease. BJU Int. 2008; (11): 1539-43
- Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy. Eur Urol. 2008; (4): 767-75; discussion 775-6
- Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy. J Urol. 2008; (5): 1780-4; discussion 1784
- The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer. Urol Oncol. 2007 May-Jun; (3): 228-35
- Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol. 2007; (5): 1933-7; discussion 1937-8
- Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy. J Urol. 2007; (4 Pt 1): 1311-5
- Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation. Nat Protoc. 2007; (8): 1931-6
- Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy. J Urol. 2007; (4 Pt 1): 1277-80; discussion 1280-1
- Update on PSA testing. J Natl Compr Canc Netw. 2007; (7): 737-42
- Visual vignette. Adrenal myelolipoma. Endocr Pract. 2006 Jan-Feb; (1): 109
- Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Cancer. 2006; (6): 1265-72
- Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J. 2006; (1): 106-8
- Genitourinary myiasis (maggot infestation). Urology. 2006; (4): 889
- High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection. J Urol. 2006; (5): 2280-4
- Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate. Urology. 2006; (1): 115-9
- Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer. World J Urol. 2006; (5): 499-508
- Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy. J Urol. 2005; (1): 135-9; discussion 139
- Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis. Urology. 2004; (2): 414-8
- Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res. 2004; (22): 7457-65
- GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. J Cell Biochem. 2004; (3): 540-52
- Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 2004; (6): 1975-86
- Laparoscopic-assisted nephrectomy with inferior vena cava tumor thrombectomy: preliminary results. Urology. 2004; (5): 925-9
- Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis. Clin Cancer Res. 2004; (21): 7276-83
- Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein. J Urol. 2004; (4 Pt 1): 1501-3
- Balloon cuffing and management of the entrapped Foley catheter. Urology. 2003; (4): 825-7
- Clinical efficacy of sildenafil citrate and predictors of long-term response. J Urol. 2003; (2 Pt 1): 503-6
- Endoscopic basket extraction of a urethral foreign body. Urology. 2003; (2): 352
- Molecular pathways to prostate cancer. J Urol. 2003; (6 Pt 1): 2444-52
- Persistent purulent drainage from the glans penis: atypical presentation of pyoderma gangrenosum. J Urol. 2003; (5): 1793-4
- Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens. Clin Cancer Res. 2003; (7): 2673-7
- Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction. Methods. 2002; (2): 150-5
- Prognostic significance of preoperative molecular serum analysis in renal cancer. Clin Cancer Res. 2002; (6): 1878-81
- Quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE). Methods. 2002; (2): 128-33
- Biological pathways to bladder carcinogenesis. Semin Urol Oncol. 2000; (4): 256-63
- Roles of cell division and gene transcription in the methylation of CpG islands. Mol Cell Biol. 1999; (10): 6690-8
- DNA methylation in bladder cancer. Eur Urol. 1998: 7-8
- Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer. Oncogene. 1998; (23): 3021-7
- The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res. 1998; (6): 1245-52
- Altered DNA methylation and genome instability: a new pathway to cancer? Proc Natl Acad Sci U S A. 1997; (6): 2103-5
- Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 1997; (4): 594-9
- Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res. 1997; (23): 5336-47
- Mutagenic and epigenetic effects of DNA methylation. Mutat Res. 1997; (2): 107-18
- Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res. 1997; (12): 2529-31
- Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res. 1996; (21): 5039-43
- The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline. J Mol Biol. 1996; (2): 240-50
- High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J Natl Cancer Inst. 1995; (18): 1383-93
- Comparison of strategies to detect and quantitate uniquely marked cells in intra- and inter-species hemopoietic chimeras. Cytometry. 1992; (4): 356-67
- Hemopoietic chimerism in rodents transplanted in utero with fetal human hemopoietic cells. Transplant Proc. 1992; (2): 542-3
Help
Trial Administration